How should a patient taper off nightly temazepam 30 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Taper Off Temazepam 30mg

Use a gradual taper reducing the dose by approximately 25% every 1-2 weeks, extending over at least 4-8 weeks, with the final doses being much smaller than typical therapeutic minimums to minimize withdrawal reactions. 1

Tapering Protocol

The FDA label explicitly states to "use a gradual taper to discontinue temazepam or reduce the dosage" with a patient-specific plan 1. Based on the evidence and established benzodiazepine tapering principles, here's the recommended approach:

Specific Tapering Schedule for 30mg Nightly

  • Week 1-2: Reduce to 22.5mg (25% reduction)
  • Week 3-4: Reduce to 15mg
  • Week 5-6: Reduce to 10mg
  • Week 7-8: Reduce to 7.5mg
  • Week 9-10: Reduce to 5mg
  • Week 11-12: Reduce to 2.5mg or less before complete discontinuation

The taper should extend to doses well below the standard therapeutic minimum of 7.5mg 1. Research on benzodiazepine discontinuation demonstrates that tapers extending over months and reaching very small final doses are more successful than the traditional 2-4 week tapers 2, 3.

Key Principles

If withdrawal symptoms emerge at any step, pause the taper or increase back to the previous dose level, then proceed more slowly 1. This is critical—the FDA explicitly recommends this approach for managing withdrawal reactions.

Patients at highest risk for severe withdrawal include those taking higher doses and those with longer duration of use 1. Since 30mg represents the maximum recommended dose, this patient is at elevated risk and warrants a conservative, slow taper.

Expected Withdrawal Symptoms

Monitor for these common benzodiazepine withdrawal symptoms 1:

  • Anxiety, insomnia (rebound), irritability
  • Tremor, muscle pain and stiffness
  • Gastrointestinal symptoms (nausea, vomiting, diarrhea)
  • Headache, dizziness, fatigue
  • Tachycardia, hypertension, sweating

Severe withdrawal reactions can include seizures, which are life-threatening 1. Abrupt discontinuation must be avoided.

Critical Warnings

Rebound insomnia is expected, particularly in the first nights after dose reduction 4. Even brief use of temazepam 30mg has been shown to produce rebound insomnia upon withdrawal, with total wake time increasing 39-61% above baseline 4. This does not indicate treatment failure—it's a predictable pharmacological effect that typically resolves.

Protracted withdrawal syndrome can occur, with symptoms persisting weeks to over 12 months 1. Symptoms include anxiety, cognitive impairment, depression, insomnia, and motor symptoms. This makes it difficult to distinguish withdrawal from recurrence of the original insomnia.

Common Pitfalls to Avoid

  • Don't taper too quickly: Traditional 2-4 week tapers show minimal benefit over abrupt discontinuation 3. The evidence supports tapers over months.
  • Don't stop at 7.5mg: While this is the "minimum therapeutic dose," stopping here often triggers withdrawal. Taper to much lower doses (2.5mg or less) 2, 3.
  • Don't mistake withdrawal for insomnia recurrence: Rebound insomnia is pharmacological withdrawal, not treatment failure 4.
  • Don't combine with other CNS depressants during taper: Particularly avoid opioids and alcohol, which dramatically increase risk of respiratory depression and death 1.

Alternative Approach

Research suggests that for high-dose benzodiazepine withdrawal (>40mg diazepam equivalent daily), inpatient tapering at 10% per day may be appropriate 2. However, since 30mg temazepam is approximately 15mg diazepam equivalent, the outpatient gradual taper described above is more appropriate.

A masked taper approach combined with cognitive behavioral therapy for insomnia (CBTI) has shown superior discontinuation rates (73% vs 59%) compared to standard unmasked tapers 5. Consider referral for CBTI during the taper process.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.